GEN Exclusives

More »

GEN Poll

More »
Oct 31, 2013

Clinical Genomics

Scientists recently reported that the use of next-generation sequencing may help improve the treatment strategies for advanced cancer patients with progressing tumors. The study highlighted some challenges that could be holding clinical genomics back. What do you think is the biggest obstacle?

What is the main obstacle holding back clinical genomics?

Cost of sequencing
Sequencing’s inherent limitations
Reporting delays/information custody issues
Complexity of sharing and understanding data

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Sustainability in New Dietary Guidelines

Do you think that sustainability considerations should be incorporated into the new Dietary Guidelines for Americans?

More »